Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
03/1993
03/31/1993EP0534396A2 2-Substituted indane-2-carboxyalkyl derivatives useful as inhibitors of enkephalinase and ace
03/31/1993EP0534363A2 Novel 2-substituted indane-2-mercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace
03/31/1993EP0533920A1 THIOPYRANO 2,3-b]INDOLE DERIVATIVE
03/31/1993EP0533846A1 The ciliary neurotrophic factor receptor
03/31/1993EP0533845A1 USING 5,10,15,20-TETRAKIS(r-CARBOXYPHENYL)PORPHINE FOR DETECTING AND TREATING LUNG CANCER
03/31/1993EP0533837A1 Inhibition of 5-lipoxygenase and cyclooxygenase pathway mediated diseases
03/31/1993EP0533820A1 Pharmaceutical preparation.
03/31/1993EP0533796A1 STEROIDAL 3-ACETIC ACID DERIVATIVES AS 5$g(a)-REDUCTASE INHIBITORS
03/31/1993EP0533724A1 Calcium citrate malate composition.
03/31/1993EP0479799A4 Wound healing
03/31/1993EP0466854A4 T cell growth factor
03/31/1993EP0407461B1 Novel cyclopentano-vitamin d analogs
03/31/1993EP0265514B1 Medicaments for inhibiting skin wrinkling
03/31/1993CN1070409A Prodrug activated by targeted catalytic proteins
03/31/1993CN1070404A Heterocyclic derivatives
03/31/1993CN1070399A Substituted amide derivatives of piperizinylcamphorsulfonyl oxytocin antagonists
03/31/1993CA2079290A1 Activities of mk protein
03/30/1993US5198567 Benzonorbornene derivatives, processes for their preparation and medicinal and cosmetic compositions containing them
03/30/1993US5198552 Indole derivative having antiviral, interferon-inducing and immunomodulatory effects
03/30/1993US5198438 Angiotensin ii antagonists incorporating a substituted thiophene or furan
03/30/1993US5198434 Angiotensin ii antagonizing fused pyridinyloxy containing derivatives
03/30/1993US5198422 Complex With Aromatic Aldehyde, Sustained Release
03/30/1993US5197973 Polypeptide
03/30/1993CA1315480C Phosphopeptides
03/30/1993CA1315287C Substituted bis-(4-aminophenyl)-sulfones, their preparation and their use as pharmaceutical compositions
03/28/1993CA2079185A1 Dicyclic nitrogens derivatives, preparation process thereof and pharmaceutical compositions containing them
03/26/1993CA2079079A1 Quinazolinones and pyridopyrimidinones
03/26/1993CA2079016A1 Ethers of thienocyclopentanone oximes, their preparation and pharmaceutical compositions containing them
03/24/1993EP0533344A1 Methanoanthracenes as dopamine antagonists
03/24/1993EP0533280A1 Novel medical use for tachykinin antagonists
03/24/1993EP0533084A1 Pharmaceutical compositions comprising natriuretic peptides or neutral endopeptidase inhibitors for treating and preventing myointimal proliferation
03/24/1993EP0532752A1 Compound tan-1251, its derivatives, their production and use
03/24/1993EP0532674A1 Leukotriene antagonists
03/24/1993EP0532634A1 Phthalamic acids and their isomers for treating leukotriene-related diseases
03/24/1993EP0532621A1 Amide linked pyridyle-benzoic acid derivatives for treating leukotriene-related diseases
03/24/1993EP0532550A1 Benzoic acid derivatives for treating leukotriene-related diseases
03/24/1993EP0532531A1 Phenol and pyridinol derivatives as pharmaceuticals
03/24/1993CN1070190A Heterocyclically substituted quinolylmethoxy-phenylacetamides
03/24/1993CA2078712A1 Composition comprising amino acids for the prevention of hypoxic damage and a process for its preparation
03/23/1993US5196576 Chelating compounds and their use
03/23/1993US5196570 Leukotriene-b4 derivatives, process for their production and their use as pharmaceutical agents
03/23/1993US5196511 Peptides and antibodies that inhibit integrin-ligand binding
03/23/1993US5196447 Neristatin 1
03/23/1993US5196411 17β-acyl-3-carboxy-androsta-3,5-dienes as testosterone 5α-reductase inhibitors
03/23/1993US5196185 Collagen-based wound dressing and method for applying same
03/23/1993CA1314906C Didehydro vitamin d -derivatives
03/23/1993CA1314903C Amides of cyclomethylen-1,2-bicarboxylic acids having therapeutical activity, processes for their preparation and pharmaceutical compositions containing them
03/23/1993CA1314899C2 Epoxides
03/23/1993CA1314891C Acetylenes disubstituted with a phenyl group and a heterobicyclic group having retinoid like activity
03/23/1993CA1314882C Substituted piperidines or azepines, the preparation thereof and their application in therapy
03/23/1993CA1314879C Anellated indole derivatives
03/23/1993CA1314871C Steroids useful as anti-cancer, anti-obesity, anti-hyperglycemic, anti-autoimmune and anti-hypercholesterolemic agents
03/18/1993WO1993005169A1 Hybrid cytokines
03/18/1993WO1993005166A1 Methods for the selection, separation and fusion of cells
03/18/1993WO1993005071A1 INTERLEUKIN 1β PROTEASE AND INTERLEUKIN 1β PROTEASE INHIBITORS
03/18/1993WO1993005064A1 Steroid sulphatase inhibitors
03/18/1993WO1993005063A1 Steroid sulphatase inhibitors
03/18/1993WO1993005040A1 Azabicyclic compounds as 5-ht4 receptor antagonists
03/18/1993WO1993005038A1 5-ht4 receptor antagonists
03/18/1993WO1993005035A1 Quinazoline derivatives and their preparation
03/18/1993WO1993005019A1 Indole derivatives as 5-alpha-reductase inhibitor
03/18/1993WO1993005014A1 Aromatic sulfonamide derivatives, their use as enzyme inhibitors and pharmaceutical compositions containing them
03/18/1993WO1993005012A1 New compounds
03/18/1993WO1993004710A2 Methods and compositions for the treatment and repair of defects or lesions in cartilage or bone
03/18/1993WO1993004691A1 Compositions and methods for treating wounds
03/18/1993WO1993004688A1 Pharmaceutical preparation containing an uricosuric and an excitatory amino acid antagonist
03/18/1993DE4130546A1 Knochenwachstumsfoerdernde zusammensetzung Knochenwachstumsfoerdernde composition
03/18/1993DE4130545A1 Knochenwachstumsfoerdernde zusammensetzung Knochenwachstumsfoerdernde composition
03/18/1993CA2305767A1 Steroid sulphatase inhibitors
03/18/1993CA2305758A1 Steroid sulphatase inhibitors
03/18/1993CA2305749A1 Steroid sulphatase inhibitors
03/18/1993CA2118798A1 Azabicyclic compounds as 5-ht4 receptor antagonists
03/18/1993CA2118697A1 Indole derivatives as 5-alpha-reductase inhibitor
03/18/1993CA2117075A1 Quinazoline derivatives and their preparation
03/18/1993CA2117070A1 Methods for the selection, separation and fusion of cells
03/18/1993CA2116549A1 Compositions and methods for treating wounds
03/18/1993CA2116533A1 Hybrid cytokines
03/18/1993CA2115161A1 New compounds
03/17/1993EP0532456A1 1-Acylpiperidine derivatives and their use as substance P antagonists
03/17/1993EP0532410A1 N-substituted heterocyclic derivatives as angiotensin II inhibitors
03/17/1993EP0532239A1 Benzenesulphonamide derivatives as 5-lipoxygenase inhibitors
03/17/1993EP0532190A2 Benzo f quinolinones as 5-alpha-reductase inhibitors
03/17/1993EP0532178A1 Methanoanthracenes as dopamine antagonists
03/17/1993EP0532097A1 Piperazinyl(sulfon)amide derivatives of camphor as oxytocin antagonists
03/17/1993EP0532027A1 Cyclic nitrones, their preparation and pharmaceutical compositions containing them
03/17/1993EP0531901A2 Condensed pyrazole derivatives with interleukin-1 and tumour necrosis factor inhibitory activity
03/17/1993EP0531876A2 Imidazoindolizine derivatives and process for preparation thereof
03/17/1993EP0531548A1 Carbostyril derivatives as anti-thrombotic agents
03/17/1993EP0531472A1 Humanized and chimeric monoclonal antibodies
03/17/1993EP0531434A1 Improved pseudomonas exotoxins of low animal toxicity and high cytocidal activity
03/17/1993EP0531425A1 Wound healing
03/17/1993EP0531382A1 N-substituted-1,2,4-triazolone compounds for treatment of cardiovascular disorders
03/17/1993EP0531365A1 Diagnosis and treatment of viral hepatitis
03/17/1993EP0360821B1 Pharmaceutical compositions for treating adrenoleukodystrophy
03/17/1993CN1069973A Corbostyril derivatives and pharmaceutical compostions contaiming same
03/17/1993CN1069971A Novel sulfonamide fibrinogen receptor antagonists
03/17/1993CN1020102C Preparation for bicyclic carboxylic ether and bicyclic carboxylic amide
03/17/1993CN1020098C Production for thiolactam-N-acetic acid derivatives
03/17/1993CN1020093C 1-phenyl -3-naphthalenyloxypropanamines
03/16/1993US5194605 Cyclic renin inhibitors containing 2-substituted (3S,4S)-4-amino-5-cyclohexyl-3-hydroxy pentanoic acid, 2-substituted (3S,4S)-5-cyclohexyl-3,4-di-hydroxy pentanoic acid or 2-substituted (4S,5S)-5-amino-6-cyclohexyl-4-hydroxyhexanoic acid or its analogs